GPS1 and neoplasm: Previous research has shown that BNC1 serves as a key transcriptional activator in esophageal squamous cell carcinoma and that LINC01305 recruits BNC1 to act on G-protein pathway suppressor 1 to promote tumor progression (Xiong et al., 2023).